You are here
Vincenzo Rispoli, MD - Neurologist
University magna Graecia of Catanzaro; Italy
Areas of Interest:
Alzheimer’s disease, In vivo animal models of Alzheimer’s disease, EEG, Behavioral testing in pharmacology, disease-modifying drugs, Aging in Long Term Care.
Biography & Research:
Vincenzo Rispoli is Aggregate Professor of Neuropharmarcology at University Magna Græcia of Catanzaro, Department of Health Sciences. He received his M.D. from the School of Medicine at the University “Federico II” of Naples in 1983. He trained in clinical Neurology and became Specialist in clinical Neurology at University Federico II of Naples in 1988. Visiting scientist at Department of Neuroscience of Institute of Psychiatry, King’s College of London in 1990, where he focused its attention on the cholinergic transmission after selective brain lesions and neural transplants in animal models of Alzheimer’s disease. In 1994 to 1995 was Visiting researcher at Institute of Pharmacology, University of Rome Tor Vergata. He currently is Head of Neuropharmacology and Preclinical Research Unit at Department of Health Science, University Magna Græcia of Catanzaro. Vincenzo Rispoli lectures to graduate and undergraduate students about Neuropsychopharmacology, Clinical Pharmacology, Experimental Neuropsychopharmacology and Applied Pharmacology. Research Interests: His main research interests concern the pharmacological evaluation of new compounds acting on different molecular targets involved in the pathogenesis of AD, with special focus on modifying-disease drugs, in animal models of Alzheimer’s disease. These studies are carried out in collaboration with several experimental neuroscience groups in developing original compounds for neurodegenerative disorders. In particular, Dipartimento di Chimica e Tecnologia delle Sostanze Biologicamente Attive University of Rome “La Sapienza”, CNR, Istituto di Chimica Biomolecolare of Naples, CNR Institute of Neurological Sciences, Section of Pharmacology of Catanzaro. He is author of patented drugs for Alzheimer’s disease. Other topic: brain neurotransmission in arousal, attention and learning.